Track AARD and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
AARD - Aardvark Therapeutics, Inc. Common Stock (AARD) has a free cash flow of -$54.27M, down 198.2% over the past year.
FCF TTM
-$54.27M
FCF Margin
-
FCF Yield
-37.31%
5Y CAGR
-
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$54.27M | -198.24% |
| 2024 | -$18.20M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q4 2025 | -$14.42M | +22.13% |
| Q3 2025 | -$18.52M | -86.42% |
| Q2 2025 | -$9.94M | +12.76% |
| Q1 2025 | -$11.39M | -47.26% |
| Q4 2024 | -$7.73M | -95.28% |
| Q3 2024 | -$3.96M | +8.08% |
| Q2 2024 | -$4.31M | -96.26% |
| Q1 2024 | -$2.19M | -89.88% |
| Q4 2023 | -$1.16M | +27.07% |
| Q3 2023 | -$1.58M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.